Dobutamine echocardiography in idiopathic dilated cardiomyopathy: Clinical and prognostic implications

European Journal of Heart Failure

Volumn 4, Issue 1, 2002, Pages 49-61

  Pinamonti, Bruno ^a   Perkan, Andrea ^a   Di Lenarda, Andrea ^a   Gregori, Dario ^b   Sinagra, Gianfranco ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Blockers; Contractile reserve; Dobutamine echocardiography; Idiopathic dilated cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; METOPROLOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART VENTRICLE FILLING; HUMAN; IMAGE ANALYSIS; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOMYOPATHY, DILATED; CHILD; CONFIDENCE INTERVALS; DOBUTAMINE; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0036154635     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00208-2     Document Type: Article

References (39)

1. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
2. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease
3. Dobutamine stress echocardiography: Detection of coronary artery disease in patients with dilated cardiomyopathy
4. Regional wall motion analysis by dobutamine stress echocardiography to distinguish between ischemic and non-ischemic dilated cardiomyopathy
5. Beta-adrenergic contractile reserve as a predictor of clinical outcome in patients with idiopathic dilated cardiomyopathy
6. Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent-onset idiopathic dilated cardiomyopathy
7. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: Relation to exercise capacity and clinical outcome
8. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol
9. The paradox of beta-adrenergic blockade for the management of congestive heart failure
10. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Results of the metoprolol in dilated cardiomyopathy (MDC) trial. A randomised, double-blind, placebo-controlled multi-center study
11. A randomized trial of betablockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS)
12. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
13. Metoprolol in dilated cardiomyopathy: Is it possible to identify factors predictive of improvement?
14. Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
15. Myocarditis: A histopathologic definition and classification
16. Heart failure in outpatients: A randomized trial of digoxin versus placebo
17. The Committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements
18. Left ventricular volumes determined by two-dimensional echocardiography in a normal adult population
19. Echocardiographic findings in myocarditis
20. The spectrum of left ventricular size in dilated cardiomyopathy: Clinical correlates and prognostic implications
21. Relation of transmitral flow velocity patterns to left ventricular diastolic function: New insight from a combined hemodynamic and Doppler echocardiographic study
22. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: Clinical, echocardiographic and hemodynamic correlations and prognostic implications
23. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: Angiographic and haemodynamic correlations
24. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: An ominous prognostic sign
25. Effect of a heart failure program on hospitalisation frequency and exercise tolerance
26. Cardiac transplantation
27. Dobutamine: A new synthetic cardioactive sympathetic amine
28. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts
29. Physiologic mechanisms governing hemodynamic responses to positive inotropic therapy in patients with dilated cardiomyopathy
30. Effects of β-adrenergic agents on systolic and diastolic myocardial function in patients with and without heart failure
31. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy
32. Effect of dobutamine and OPC-18790 on diastolic chamber stiffness in patients with idiopathic dilated cardiomyopathy
33. Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: A Doppler echocardiographic study
34. Dynamic mitral regurgitation: An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure
35. Effect of dobutamine stress echocardiography on mitral regurgitation
36. Evaluation of contractile reserve by dobutamine echocardiography: Non-invasive estimation of the severity of heart failure
37. Spontaneous hemodynamic improvement or stabilisation and associated biopsy findings in patients with congestive cardiomyopathy
38. Milrinone and dobutamine in severe heart failure: Differing hemodynamic effects and individual patient responsiveness
39. Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy